July 22, 2009 – Before implementing an electronic health record (EHR) system, providers must first gain control of the number of records, forms and files flowing through the organization, and a recent Xerox Corp. study explained issues involved.
July 22, 2009 – Cardica Inc. today announced the full results of the PAS-Port system multicenter pivotal trial, known as the EPIC trial, were published in the July issue of the peer-reviewed publication The Journal of Thoracic and Cardiovascular Surgery.
July 22, 2009 – Roche Diagnostics today introduced the Roche Cardiac 200, a comprehensive testing solution for rapid cardiac diagnostic needs in point-of-care testing environments.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 21, 2009 – Total procedures performed in angio labs from 2004 to 2008 grew 20 percent, from 4 million in 2004 to 4.8 million procedures in 2008 for hospitals with 150 plus beds, resulting in an average annual growth rate of 4-5 percent, according to a recent report released by IMV.
Jul y 21, 2009 – St. Jude Medical Inc. today said the FDA cleared its Accent RF pacemaker and Anthem RF CRT-P (cardiac resynchronization therapy pacemaker). The company also announced FDA and European CE mark approval of version 4.0 of the Merlin.net Patient Care Network (PCN), which supports the Accent RF and Anthem RF devices.
When stenting emerged as a minimally- invasive treatment for clogged arteries associated with peripheral artery disease (PAD), medical experts raised concerns that delivery of stents through the vasculature could potentially knock loose plaque built up on the inside of the artery walls.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
In the current economy where hospitals are tightening their belts to help get through tough times, technology can aid in cost cutting by increasing physician and staff efficiency.
There is growing interest in going beyond using ventricular assist devices (VADs) just for end-stage heart failure and expanding use for therapeutic recovery in patients with cardiogenic shock, stage III heart failure and to increase perfusion during acute myocardial infarction (AMI).
The use of remote, prehospital ECG transmission systems by emergency medical services (EMS) can help quickly identify ST-elevated myocardial infarctions (STEMI) and allow earlier activation of the cath lab prior to the patient’s arrival at the hospital. Users of these systems say earlier diagnosis and cath lab activation is key to significantly reduce door-to-balloon (D2B) times.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
There are many avenues for the improvement of cath lab inventory control to become more efficient with the emphasis being not faster, but smarter, avoiding waste, and without jeopardizing patient safety. Many different methods are now available to assist in managing inventory.
Interventionalists using radial instead of femoral access say it significantly cuts bleeding complications, infection rates, readmissions and aids patient comfort and ambulation.
July 20, 2009 - ATS Medical Inc. today announced the first commercial use of the new ATS CryoMaze 10-S Surgical Cryoablation Probe for the treatment of cardiac arrhythmias.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
There has been a growing trend in electrophysiology toward remote, home monitoring of implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT) devices, pacemakers and implantable cardiac monitors. These systems were displayed prominently on the show floor and discussed in several sessions in May at Heart Rhythm 2009 in Boston.
July 17, 2009 – AGA Medical Corp. received European CE mark approval for its AMPLATZER vascular plug, AVP 4, which is indicated for arterial and venous embolizations in the peripheral vasculature.
July 17, 2009 – Medtronic announced today the completion of a 12-month follow-up in the STOP-AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial evaluating the first cryoballoon catheter technology designed to treat paroxysmal atrial fibrillation: the Medtronic Arctic Front CryoAblation Catheter System.